|
End-of-day quote
Korea S.E.
2026-08-24
|
5-day change | 1st Jan Change | ||
| 4,240.00 KRW | +0.83% |
|
-8.23% | -38.37% |
| 04-13 | Genome & Company announced that it has received KRW 6.99999414 billion in funding | CI |
| 04-02 | Genome & Company announced that it expects to receive KRW 6.99999414 billion in funding | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.83% | -8.23% | +13.67% | -24.96% | -38.37% | +70.62% | -52.89% | -81.44% | - | 160M | |
| +0.78% | +4.77% | +5.97% | +20.61% | +10.23% | +3.49% | +25.25% | -22.87% | +217.68% | 51.21B | |
| +1.01% | -0.20% | +11.81% | +39.60% | +165.64% | +471.68% | +564.93% | +715.65% | - | 45.35B | |
| +0.16% | +7.88% | +25.09% | +55.00% | +15.45% | +36.14% | +20.76% | +1.32% | +245.10% | 42.84B | |
| -0.66% | +2.61% | +14.14% | +19.90% | +22.44% | +18.59% | +87.04% | +30.30% | +1,228.50% | 42.29B | |
| +0.88% | -3.48% | +9.23% | +2.52% | +12.54% | +17.20% | +53.83% | -16.47% | +148.72% | 32.15B | |
| -0.12% | +3.84% | +3.10% | +43.26% | +10.39% | +33.73% | +145.25% | +244.19% | +2,108.08% | 17.31B | |
| -0.53% | +1.84% | -0.75% | +1.98% | - | - | - | - | - | 16.55B | |
| +0.14% | +5.37% | +9.68% | +16.07% | +17.63% | +9.98% | +31.40% | -38.03% | +99.51% | 14.84B | |
| +1.15% | +4.17% | +31.78% | +86.26% | +49.68% | +84.49% | +50.33% | -30.16% | +264.48% | 14.25B | |
| +0.73% | +2.38% | +4.66% | +48.55% | -4.80% | -1.34% | -31.42% | -30.40% | +131.25% | 13.38B | |
| -8.97% | +28.14% | +55.00% | +43.29% | +12.06% | -17.82% | - | - | - | 11.94B | |
| -6.50% | -10.48% | +16.43% | +73.00% | +57.79% | +49.04% | +57.24% | -48.50% | - | 11.27B | |
| +0.10% | 0.00% | +1.10% | +50.16% | +23.09% | +26.80% | -8.12% | -41.20% | +175.93% | 11.35B | |
| +3.67% | -1.17% | -10.16% | -11.64% | -15.53% | +55.50% | +498.24% | +255.59% | +2,507.69% | 10.71B | |
| -2.10% | -2.22% | +13.14% | +7.12% | +24.87% | +654.47% | +1,690.90% | +32.91% | - | 10.28B | |
| +0.03% | +0.15% | +0.38% | +66.08% | +78.58% | +252.21% | +445.71% | - | - | 10.17B | |
| +0.26% | -2.46% | +13.67% | +55.98% | +77.15% | +169.17% | +702.07% | +211.50% | +1,314.26% | 10.01B | |
| +1.04% | -0.30% | +9.48% | +53.44% | +55.57% | +174.49% | +525.58% | +120.45% | - | 10.07B | |
| +3.85% | +5.82% | +9.71% | -17.89% | -21.58% | +45.33% | +55.84% | +55.18% | +96.08% | 10.31B | |
| Average | -0.21% | +2.06% | +11.86% | +31.42% | +29.10% | +113.36% | +270.11% | +79.88% | +711.44% | 19.32B | |
| Weighted average by Cap. | +0.01% | +2.62% | +12.24% | +32.26% | +38.35% | +110.39% | +215.59% | +117.50% | +609.16% |
- Stock Market
- Stocks
- A314130 Stock
- Sector Genome & Company
Select your edition
All financial news and data tailored to specific country editions
